On the public citation graph
3-(1 H -Tetrazol-5-yl)-1,4,5,6-tetrahydro-cyclopentapyrazole (MK-0354): A Partial Agonist of the Nicotinic Acid Receptor, G-Protein Coupled Receptor 109a, with Antilipolytic but No Vasodilatory Activity in Mice
0 signed · 119 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1016/0092-8674(93)90666-eopenalex-snapshot
cPLA2 is phosphorylated and activated by MAP kinase
inferredcites →https://doi.org/10.1016/j.bmcl.2007.06.028openalex-snapshot
Agonist lead identification for the high affinity niacin receptor GPR109a
inferredcites →https://doi.org/10.1016/j.bmcl.2007.07.101openalex-snapshot
Fluorinated pyrazole acids are agonists of the high affinity niacin receptor GPR109a
inferredcites →https://doi.org/10.1016/j.tips.2006.05.008openalex-snapshot
The nicotinic acid receptor GPR109A (HM74A or PUMA-G) as a new therapeutic target
inferredcites →https://doi.org/10.1016/s0026-895x(24)12846-5openalex-snapshot
Characterization of a G Protein-Coupled Receptor for Nicotinic Acid
inferredcites →https://doi.org/10.1016/s0735-1097(86)80293-5openalex-snapshot
Fifteen year mortality in Coronary Drug Project patients: Long-term benefit with niacin
inferredcites →https://doi.org/10.1021/jm030888copenalex-snapshot
Pyrazole Derivatives as Partial Agonists for the Nicotinic Acid Receptor
inferredcites →https://doi.org/10.1021/jm070022xopenalex-snapshot
Analogues of Acifran: Agonists of the High and Low Affinity Niacin Receptors, GPR109a and GPR109b
inferredcites →https://doi.org/10.1038/nm824openalex-snapshot
PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect
inferredcites →https://doi.org/10.1056/nejmoa011090openalex-snapshot
Simvastatin and Niacin, Antioxidant Vitamins, or the Combination for the Prevention of Coronary Disease
inferredcites →https://doi.org/10.1073/pnas.0601574103openalex-snapshot
Antagonism of the prostaglandin D 2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans
inferredcites →https://doi.org/10.1074/jbc.c500213200openalex-snapshot
(d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-G
inferredcites →https://doi.org/10.1074/jbc.m210695200openalex-snapshot
Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid
inferredcites →https://doi.org/10.1074/jbc.m701866200openalex-snapshot
Nicotinic Acid Receptor Agonists Differentially Activate Downstream Effectors
inferredcites →https://doi.org/10.1111/1523-1747.ep12499963openalex-snapshot
Identification of Skin as a Major Site on Prostaglandin D2 Release Following Oral Administration of Niacin in Humans
inferredcites →https://doi.org/10.1111/j.1365-2796.2005.01528.xopenalex-snapshot
Nicotinic acid: the broad‐spectrum lipid drug. A 50th anniversary review
inferredcites →https://doi.org/10.1124/mol.106.030833openalex-snapshot
Nicotinic Acid-Induced Flushing Is Mediated by Activation of Epidermal Langerhans Cells
inferredcites →https://doi.org/10.1161/01.cir.0000148955.19792.8dopenalex-snapshot
Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2
inferredcites →https://doi.org/10.1161/01.cir.103.17.2213openalex-snapshot
Low High-Density Lipoprotein Cholesterol as a Risk Factor in Coronary Heart Disease
inferredcites →https://doi.org/10.1172/jci23626openalex-snapshot
GPR109A (PUMA-G/HM74A) mediates nicotinic acid–induced flushing
inferredcites →https://doi.org/10.1177/030006058901700411openalex-snapshot
Results of a Phase IV Study Carried Out with Acipimox in Type II Diabetic Patients with Concomitant Hyperlipoproteinaemia
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1002/0471266949.bmc193openalex-snapshot
Atherosclerosis II : HDL Elevation
inferred← citeshttps://doi.org/10.1002/9783527647828.ch7openalex-snapshot
Literature Survey Part C: Heterocycle Synthesis
inferred← citeshttps://doi.org/10.1002/cpdd.704openalex-snapshot
A Randomized, Placebo‐Controlled Trial to Assess the Effects of 8 Weeks of Administration of GSK256073, a Selective GPR109A Agonist, on High‐Density Lipoprotein Cholesterol in Subjects With Dyslipidemia
inferred← citeshttps://doi.org/10.1002/jhet.1504openalex-snapshot
Synthetic Routes to Pyrazole‐3(5)‐carboxylates
inferred← citeshttps://doi.org/10.1007/164_2017_50openalex-snapshot
Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors
inferred← citeshttps://doi.org/10.1007/164_2025_767openalex-snapshot
Structural Perspectives on Biased Allostery of GPCR Signaling
inferred← citeshttps://doi.org/10.1007/7355_2017_14openalex-snapshot
Biased Agonist Pharmacochaperones: Small Molecules in the Toolbox for Selectively Modulating GPCR Activity
inferred← citeshttps://doi.org/10.1007/s11030-009-9138-8openalex-snapshot
Controlled microwave heating in modern organic synthesis: highlights from the 2004–2008 literature
inferred← citeshttps://doi.org/10.1007/s11302-011-9232-0openalex-snapshot
Functional selectivity of adenosine receptor ligands
inferred← citeshttps://doi.org/10.1007/s11883-013-0325-9openalex-snapshot
GPR109A and Vascular Inflammation
inferred← citeshttps://doi.org/10.1007/s11883-016-0570-9openalex-snapshot
Niacin Alternatives for Dyslipidemia: Fool’s Gold or Gold Mine? Part II: Novel Niacin Mimetics
inferred← citeshttps://doi.org/10.1016/b978-0-12-385952-5.00005-1openalex-snapshot
Biological and Pharmacological Roles of HCA Receptors
inferred← citeshttps://doi.org/10.1016/b978-0-12-385952-5.00009-9openalex-snapshot
Refining Efficacy: Exploiting Functional Selectivity for Drug Discovery
inferred← citeshttps://doi.org/10.1016/b978-0-12-394440-5.00012-7openalex-snapshot
Arrestins in the Cardiovascular System
inferred← citeshttps://doi.org/10.1016/b978-0-12-394440-5.00018-8openalex-snapshot
Arrestin Pathways as Drug Targets
inferred← citeshttps://doi.org/10.1016/bs.ircmb.2018.02.007openalex-snapshot
Biased Agonism/Antagonism of Cardiovascular GPCRs for Heart Failure Therapy
inferred← citeshttps://doi.org/10.1016/j.apcatb.2022.121368openalex-snapshot
One-pot conversion of lignocellulosic biomass to ketones and aromatics over a multifunctional Cu–Ru/ZSM-5 catalyst
inferred← citeshttps://doi.org/10.1016/j.bbrc.2011.07.087openalex-snapshot
Impedance measurement: A new method to detect ligand-biased receptor signaling
inferred← citeshttps://doi.org/10.1016/j.biocel.2016.04.016openalex-snapshot
Angiotensin II receptors and peritoneal dialysis-induced peritoneal fibrosis
inferred← citeshttps://doi.org/10.1016/j.bmc.2015.02.018openalex-snapshot
Affinity and kinetics study of anthranilic acids as HCA2 receptor agonists
inferred← citeshttps://doi.org/10.1016/j.bmcl.2009.06.054openalex-snapshot
Pyrazole acids as niacin receptor agonists for the treatment of dyslipidemia
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.03.062openalex-snapshot
Potent tricyclic pyrazole tetrazole agonists of the nicotinic acid receptor (GPR109a)
inferred← citeshttps://doi.org/10.1016/j.bmcl.2010.07.108openalex-snapshot
Pyrido pyrimidinones as selective agonists of the high affinity niacin receptor GPR109A: Optimization of in vitro activity
inferred← citeshttps://doi.org/10.1016/j.bmcl.2020.127105openalex-snapshot
Discovery of novel pyrrole derivatives as potent agonists for the niacin receptor GPR109A
inferred← citeshttps://doi.org/10.1016/j.cell.2024.11.001openalex-snapshot
Structure-guided design of a peripherally restricted chemogenetic system
inferred← citeshttps://doi.org/10.1016/j.cellsig.2013.06.008openalex-snapshot
Differential tissue and ligand-dependent signaling of GPR109A receptor: Implications for anti-atherosclerotic therapeutic potential
inferred← citeshttps://doi.org/10.1016/j.cmet.2017.03.008openalex-snapshot
GPCR-Mediated Signaling of Metabolites
inferred← citeshttps://doi.org/10.1016/j.ejphar.2015.01.051openalex-snapshot
Discovery and characterization of GSK256073, a non-flushing hydroxy-carboxylic acid receptor 2 (HCA2) agonist
inferred← citeshttps://doi.org/10.1016/j.glycos.2026.100049openalex-snapshot
Functional reversals and fate switches driven by posttranslational modifications: Insights from advanced techniques
inferred← citeshttps://doi.org/10.1016/j.isci.2026.116030openalex-snapshot
Comparative analysis reveals molecular adaptation of mammalian HCA2 to microbial metabolites
inferred← citeshttps://doi.org/10.1016/j.jacl.2008.08.445openalex-snapshot
Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans
inferred← citeshttps://doi.org/10.1016/j.jmb.2024.168795openalex-snapshot
Ligand Recognition and Activation Mechanism of the Alicarboxylic Acid Receptors
inferred← citeshttps://doi.org/10.1016/j.molmed.2010.11.004openalex-snapshot
Therapeutic potential of β-arrestin- and G protein-biased agonists
inferred← citeshttps://doi.org/10.1016/j.molmed.2015.02.002openalex-snapshot
Nutritional or pharmacological activation of HCA2 ameliorates neuroinflammation
inferred← citeshttps://doi.org/10.1016/j.phanu.2026.100506openalex-snapshot
Repositioning of niacin in atherosclerotic cardiovascular disease
inferred← citeshttps://doi.org/10.1016/j.pharep.2014.06.006openalex-snapshot
Ligand-directed trafficking of receptor stimulus
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2012.06.003openalex-snapshot
Role of HCA2 (GPR109A) in nicotinic acid and fumaric acid ester-induced effects on the skin
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2019.05.006openalex-snapshot
Biased signaling of G protein coupled receptors (GPCRs): Molecular determinants of GPCR/transducer selectivity and therapeutic potential
inferred← citeshttps://doi.org/10.1016/j.pharmthera.2025.108909openalex-snapshot
Hydroxyl carboxylic acid receptor-2 (HCAR2) as a potential target in neurometabolic diseases
inferred← citeshttps://doi.org/10.1016/j.tetlet.2015.08.008openalex-snapshot
Facile ligand-free Pd-catalyzed tandem C–C/C–N coupling reaction: a novel access to highly diverse tetrazole tag isoindoline derivatives
inferred← citeshttps://doi.org/10.1016/j.tibs.2011.06.003openalex-snapshot
Emerging paradigms of β-arrestin-dependent seven transmembrane receptor signaling
inferred← citeshttps://doi.org/10.1016/j.tips.2009.09.001openalex-snapshot
GPR109A, GPR109B and GPR81, a family of hydroxy-carboxylic acid receptors
inferred← citeshttps://doi.org/10.1016/j.tips.2011.08.002openalex-snapshot
Nicotinic acid (niacin): new lipid-independent mechanisms of action and therapeutic potentials
inferred← citeshttps://doi.org/10.1016/j.tips.2018.01.001openalex-snapshot
New Insights into Modes of GPCR Activation
inferred← citeshttps://doi.org/10.1016/s0065-7743(10)45005-8openalex-snapshot
High-Affinity Niacin Receptor GPR109A Agonists
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.6b01575openalex-snapshot
Modulators of Sphingosine-1-phosphate Pathway Biology: Recent Advances of Sphingosine-1-phosphate Receptor 1 (S1P1) Agonists and Future Perspectives
inferred← citeshttps://doi.org/10.1021/acs.jmedchem.8b00435openalex-snapshot
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure–Functional Selectivity Relationships (SFSRs) and Therapeutic Potential
inferred← citeshttps://doi.org/10.1021/acs.orglett.6c02521openalex-snapshot
Modular Synthesis of Dinitramino-Functionalized Pyrazole-Tetrazole and Its Derivatives: Achieving Superior Detonation Performance
inferred← citeshttps://doi.org/10.1021/cr300333uopenalex-snapshot
Transition Metal-Mediated Synthesis of Monocyclic Aromatic Heterocycles
inferred← citeshttps://doi.org/10.1021/jm2010964openalex-snapshot
(1aR,5aR)1a,3,5,5a-Tetrahydro-1H-2,3-diaza-cyclopropa[a]pentalene-4-carboxylic Acid (MK-1903): A Potent GPR109a Agonist that Lowers Free Fatty Acids in Humans
inferred← citeshttps://doi.org/10.1021/jm400053vopenalex-snapshot
Discovery of a New Class of Natural Product-Inspired Quinazolinone Hybrid as Potent Antileishmanial agents
inferred← citeshttps://doi.org/10.1021/jm401677gopenalex-snapshot
Biased Ligand Modulation of Seven Transmembrane Receptors (7TMRs): Functional Implications for Drug Discovery
inferred← citeshttps://doi.org/10.1021/jm900151eopenalex-snapshot
Discovery of Novel Tricyclic Full Agonists for the G-Protein-Coupled Niacin Receptor 109A with Minimized Flushing in Rats
inferred← citeshttps://doi.org/10.1021/op800290topenalex-snapshot
Development of a Scaleable Synthesis of a Partial Nicotinic Acid Receptor Agonist
inferred← citeshttps://doi.org/10.1038/nrd3024openalex-snapshot
Teaching old receptors new tricks: biasing seven-transmembrane receptors
inferred← citeshttps://doi.org/10.1038/nrd3777openalex-snapshot
G protein-coupled receptors for energy metabolites as new therapeutic targets
inferred← citeshttps://doi.org/10.1038/s41392-023-01625-yopenalex-snapshot
Orthosteric ligand selectivity and allosteric probe dependence at Hydroxycarboxylic acid receptor HCAR2
inferred← citeshttps://doi.org/10.1038/s41467-023-37177-6openalex-snapshot
Structural insights into the human niacin receptor HCA2-Gi signalling complex
inferred← citeshttps://doi.org/10.1038/s41467-023-42764-8openalex-snapshot
Structural basis for ligand recognition and signaling of hydroxy-carboxylic acid receptor 2
inferred← citeshttps://doi.org/10.1038/s41467-023-43537-zopenalex-snapshot
Orthosteric and allosteric modulation of human HCAR2 signaling complex
inferred← citeshttps://doi.org/10.1038/s41467-024-49536-yopenalex-snapshot
Multiple recent HCAR2 structures demonstrate a highly dynamic ligand binding and G protein activation mode
inferred← citeshttps://doi.org/10.1038/srep31072openalex-snapshot
Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLC
inferred← citeshttps://doi.org/10.1051/jbio/2013014openalex-snapshot
Les récepteurs couplés aux protéines G sous les feux de la rampe
inferred← citeshttps://doi.org/10.1074/jbc.m111.241372openalex-snapshot
Distinct Kinetic and Spatial Patterns of Protein Kinase C (PKC)- and Epidermal Growth Factor Receptor (EGFR)-dependent Activation of Extracellular Signal-regulated Kinases 1 and 2 by Human Nicotinic Acid Receptor GPR109A
inferred← citeshttps://doi.org/10.1074/jbc.m112.449587openalex-snapshot
Biased and Constitutive Signaling in the CC-chemokine Receptor CCR5 by Manipulating the Interface between Transmembrane Helices 6 and 7
inferred← citeshttps://doi.org/10.1097/fjc.0000000000000356openalex-snapshot
G Protein–coupled Receptor Biased Agonism
inferred← citeshttps://doi.org/10.1111/bph.12553openalex-snapshot
Gating function of isoleucine‐116 in TM ‐3 (position III :16/3.40) for the activity state of the CC ‐chemokine receptor 5 ( CCR 5)
inferred← citeshttps://doi.org/10.1111/j.1463-1326.2011.01400.xopenalex-snapshot
Future of GPR109A agonists in the treatment of dyslipidaemia
inferred← citeshttps://doi.org/10.1111/j.1476-5381.2012.02039.xopenalex-snapshot
Effects of pyrazole partial agonists on HCA2‐mediated flushing and VLDL‐triglyceride levels in mice
inferred← citeshttps://doi.org/10.1124/jpet.116.239665openalex-snapshot
Selexipag Active Metabolite ACT-333679 Displays Strong Anticontractile and Antiremodeling Effects but Low β-Arrestin Recruitment and Desensitization Potential
inferred← citeshttps://doi.org/10.1124/mol.110.068395openalex-snapshot
Agonist-Biased Signaling at the Histamine H4 Receptor: JNJ7777120 Recruits β-Arrestin without Activating G Proteins
inferred← citeshttps://doi.org/10.1124/pr.109.002436openalex-snapshot
Beyond Desensitization: Physiological Relevance of Arrestin-Dependent Signaling
inferred← citeshttps://doi.org/10.1124/pr.110.003301openalex-snapshot
International Union of Basic and Clinical Pharmacology. LXXXII: Nomenclature and Classification of Hydroxy-carboxylic Acid Receptors (GPR81, GPR109A, and GPR109B)
inferred← citeshttps://doi.org/10.1124/pr.116.013367openalex-snapshot
The Diverse Roles of Arrestin Scaffolds in G Protein–Coupled Receptor Signaling
inferred← citeshttps://doi.org/10.1126/scitranslmed.3003877openalex-snapshot
Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression
inferred← citeshttps://doi.org/10.1146/annurev-pharmtox-011613-135945openalex-snapshot
Free Fatty Acid (FFA) and Hydroxy Carboxylic Acid (HCA) Receptors
inferred← citeshttps://doi.org/10.1146/annurev.pharmtox.010909.105800openalex-snapshot
Molecular Mechanism of β-Arrestin-Biased Agonism at Seven-Transmembrane Receptors
inferred← citeshttps://doi.org/10.1152/ajpgi.00275.2020openalex-snapshot
GPCRs get fatty: the role of G protein-coupled receptor signaling in the development and progression of nonalcoholic fatty liver disease
inferred← citeshttps://doi.org/10.1161/circresaha.110.231308openalex-snapshot
Biased Ligands for Better Cardiovascular Drugs
inferred← citeshttps://doi.org/10.1172/jci36806openalex-snapshot
β-Arrestin1 mediates nicotinic acid–induced flushing, but not its antilipolytic effect, in mice
inferred← citeshttps://doi.org/10.1172/jci41651openalex-snapshot
Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells
inferred← citeshttps://doi.org/10.1172/jci42273openalex-snapshot
Nicotinic acid– and monomethyl fumarate–induced flushing involves GPR109A expressed by keratinocytes and COX-2–dependent prostanoid formation in mice
inferred← citeshttps://doi.org/10.1210/jc.2011-1104openalex-snapshot
Effects of Nicotinic Acid on Gene Expression: Potential Mechanisms and Implications for Wanted and Unwanted Effects of the Lipid-Lowering Drug
inferred← citeshttps://doi.org/10.1210/me.2013-1314openalex-snapshot
Minireview: More Than Just a Hammer: Ligand “Bias” and Pharmaceutical Discovery
inferred← citeshttps://doi.org/10.1517/13543770902798061openalex-snapshot
Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403
inferred← citeshttps://doi.org/10.1517/13543770902991526openalex-snapshot
Novel patent publications on high-affinity nicotinic acid receptor agonists
inferred← citeshttps://doi.org/10.3389/fendo.2011.00051openalex-snapshot
Biological Roles and Therapeutic Potential of Hydroxy-Carboxylic Acid Receptors
inferred← citeshttps://doi.org/10.3389/fendo.2023.1197102openalex-snapshot
Metabolite-sensing GPCRs controlling interactions between adipose tissue and inflammation
inferred← citeshttps://doi.org/10.3389/fendo.2026.1916297openalex-snapshot
Orphan GPCRs in diabetes mellitus: metabolic control, inflammation, and drug development
inferred← citeshttps://doi.org/10.3389/fimmu.2021.606384openalex-snapshot
Role of HCA2 in Regulating Intestinal Homeostasis and Suppressing Colon Carcinogenesis
inferred← citeshttps://doi.org/10.3998/ark.5550190.p008.131openalex-snapshot
A review of recent progress (2002-2012) on the biological activities of pyrazoles
inferred← citeshttps://doi.org/10.70675/140dba1fz2ba0z4eaaz9f32z9003cc60ebc5openalex-snapshot
Propriétés signalétiques des B-arrestines : mise en évidence de nouveaux partenaires et implications fonctionnelles
inferred← citeshttps://doi.org/10.70675/34a74ddbzc72dz43bczb249zd94249edd579openalex-snapshot
Synthèse totale de la laxaphycine B : un lipopeptide cyclique d’origine marine : extension à d’autres peptides apparentés.
inferred← citeshttps://doi.org/10.70675/a1c0e871ze67cz4849zba62z57e10a494cd3openalex-snapshot
Etude des bases structurales de l’efficacité et de la sélectivité fonctionnelle des récepteurs couplés aux protéines G : cas du récepteur V2 de la vasopressine
inferred← citeshttps://doi.org/10.7598/cst2017.1344openalex-snapshot
Utility of 4-Aryl-8-arylidene-3, 4, 5, 6, 7, 8-hexa-hydroquinazoline-2-thiol for the Synthesis of Some New Heterocycles as Antioxidant Agents
inferred← citeshttps://doi.org/10.7600/jpfsm.5.213openalex-snapshot
Biological roles and therapeutic potential of G protein-coupled receptors for free fatty acids and metabolic intermediates
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.